...
首页> 外文期刊>Revista Cubana de Enfermería >Respuesta al tratamiento con HeberFERON desde el diagn?3stico de enfermer?-a en pacientes con neoplasia basocelular
【24h】

Respuesta al tratamiento con HeberFERON desde el diagn?3stico de enfermer?-a en pacientes con neoplasia basocelular

机译:从疗效诊断治疗疗效诊断的疗效?-A患者基础细胞肿瘤患者

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction: In Cuba, HeberFERON introduction in the treatment of non-melanomas periocular skin neoplasms has allowed very favorable clinical and aesthetic outcomes, avoiding complex surgeries and reconstructions and obtaining very promising results. Objective: To describe the response to HeberFERON treatment in patients with basal cell neoplasia since the nursing diagnosis. Methods: Prospective, longitudinal and descriptive study carried out in the ophthalmology service of Abel Santamar?-a Cuadrado General Teaching Hospital of Pinar del R?-o, in the period from July to December 2017. The study population consisted of 12 patients with basal cell neoplasia and treated with HeberFERON. The variables analyzed were age, sex, skin phototype, location and size of the lesion, response to treatment, and nursing diagnosis. Results: 50.00% of the patients studied belonged to the age group of 71 years or older, of male sex, and whose lesion was less than 20 mm in size. 66.66% had a skin phototype II. The lesion was located in the lower eyelid and had a complete response to treatment with HeberFERON. Based on the nursing diagnosis, lack of confidence and knowledge about the disease was in 100% of the cases; fear of death, in 91.66%; deterioration of skin and tissues around, in 83.33%. Conclusions: The majority of the patients treated with HeberFERON presented a complete response to the therapy, resulting in a total disappearance of the neoplasm.
机译:介绍:在古巴,Heberferon介绍治疗非黑色素膜围眼皮肤肿瘤,允许非常有利的临床和美学结果,避免复杂的手术和重建并获得非常有前途的结果。目的:描述自护理诊断以来基底细胞瘤瘤患者对Heberferon治疗的反应。方法:在Abel Santamar的眼科服务中进行的前瞻性,纵向和描述性研究 - Pinar del R的Cuadrado General教学医院,在2017年7月至12月。研究人群由12名基础患者组成细胞瘤形成并用Heberferon治疗。分析的变量是病变的年龄,性,皮肤光学,位置和大小,治疗的反应和护理诊断。结果:50.00%所研究的患者属于年龄组71岁或以上的男性性别,其病变规模小于20毫米。 66.66%有皮肤光学型II。病变位于较低眼睑,并对Heberferon进行治疗并具有完全反应。根据护理诊断,缺乏对该疾病的信心和知识在100%的情况下;害怕死亡,91.66%;皮肤和组织周围的恶化,83.33%。结论:大多数用Heberferon治疗的患者对治疗的完全反应,导致肿瘤的总消失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号